Neuroleptic malignant syndrome.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D005334:Fever / Q000139:chemically induced*; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D009127:Muscle Rigidity / Q000139:chemically induced*; D013577:Syndrome
D014150:Antipsychotic Agents; D001971:Bromocriptine